Healthcare provider profile · identity verified

Eric Price, MD

Family Practice · WIMBERLEY, TX · NPI 1558378893

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Lisinopril	Lisinopril	462	132
Levothyroxine Sodium	Levothyroxine Sodium	460	118
Atorvastatin Calcium	Atorvastatin Calcium	377	112
Amlodipine Besylate	Amlodipine Besylate	307	86
Hydrochlorothiazide	Hydrochlorothiazide	282	87
Rosuvastatin Calcium	Rosuvastatin Calcium	281	81
Losartan Potassium	Losartan Potassium	232	66
Simvastatin	Simvastatin	222	59
Gabapentin	Gabapentin	205	55
Alprazolam	Alprazolam	194	41
Ozempic	Semaglutide	172	23
Omeprazole	Omeprazole	152	49
Zolpidem Tartrate	Zolpidem Tartrate	147	34
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	146	42
Tamsulosin Hcl	Tamsulosin Hcl	138	46
Metformin Hcl	Metformin Hcl	132	35
Trazodone Hcl	Trazodone Hcl	124	37
Clonazepam	Clonazepam	116	20
Pravastatin Sodium	Pravastatin Sodium	112	32
Celecoxib	Celecoxib	109	29
Metoprolol Succinate	Metoprolol Succinate	106	29
Albuterol Sulfate Hfa	Albuterol Sulfate	105	26
Escitalopram Oxalate	Escitalopram Oxalate	105	35
Fluticasone Propionate	Fluticasone Propionate	105	41
Diazepam	Diazepam	101	22
Montelukast Sodium	Montelukast Sodium	101	27
Glimepiride	Glimepiride	100	27
Prednisone	Prednisone	99	69
Synthroid	Levothyroxine Sodium	93	25
Alendronate Sodium	Alendronate Sodium	90	27
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	89	26
Metformin Hcl Er	Metformin Hcl	87	30
Sertraline Hcl	Sertraline Hcl	87	26
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	83	22
Meloxicam	Meloxicam	76	23
Lorazepam	Lorazepam	73	12
Allopurinol	Allopurinol	71	19
Pantoprazole Sodium	Pantoprazole Sodium	70	23
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	66	66
Duloxetine Hcl	Duloxetine Hcl	60	17
Finasteride	Finasteride	60	18
Atenolol	Atenolol	58	13
Lovastatin	Lovastatin	54	15
Estradiol	Estradiol	53	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	53	15
Tramadol Hcl	Tramadol Hcl	51	16
Furosemide	Furosemide	48	17
Bupropion Xl	Bupropion Hcl	47	18
Benazepril Hcl	Benazepril Hcl	44	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	41	14
Eszopiclone	Eszopiclone	40	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	40	15
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	39	suppressed
Myrbetriq	Mirabegron	39	suppressed
Carvedilol	Carvedilol	37	12
Amitriptyline Hcl	Amitriptyline Hcl	34	suppressed
Glipizide	Glipizide	34	suppressed
Temazepam	Temazepam	34	suppressed
Clopidogrel	Clopidogrel Bisulfate	32	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	32	11
Paroxetine Hcl	Paroxetine Hcl	32	suppressed
Trulicity	Dulaglutide	31	suppressed
Acyclovir	Acyclovir	30	14
Citalopram Hbr	Citalopram Hydrobromide	30	suppressed
Januvia	Sitagliptin Phosphate	30	suppressed
Clonidine Hcl	Clonidine Hcl	29	12
Esomeprazole Magnesium	Esomeprazole Magnesium	29	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	29	29
Shingrix	Varicella-Zoster Ge/As01b/Pf	29	25
Azithromycin	Azithromycin	28	28
Constulose	Lactulose	28	suppressed
Irbesartan	Irbesartan	28	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	27	suppressed
Jardiance	Empagliflozin	27	suppressed
Testosterone Cypionate	Testosterone Cypionate	27	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Mounjaro	Tirzepatide	24	suppressed
Propranolol Hcl	Propranolol Hcl	24	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	24	21
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	23
Methylprednisolone	Methylprednisolone	23	21
Potassium Chloride	Potassium Chloride	23	suppressed
Baclofen	Baclofen	22	suppressed
Cephalexin	Cephalexin	22	16
Ciprofloxacin Hcl	Ciprofloxacin Hcl	22	20
Ezetimibe	Ezetimibe	22	suppressed
Eliquis	Apixaban	21	suppressed
Farxiga	Dapagliflozin Propanediol	21	suppressed
Mirtazapine	Mirtazapine	21	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	15
Gemfibrozil	Gemfibrozil	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Enalapril Maleate	Enalapril Maleate	19	suppressed
Ipratropium Bromide	Ipratropium Bromide	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Solifenacin Succinate	Solifenacin Succinate	18	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	14	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Dexlansoprazole Dr	Dexlansoprazole	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Hydrocortisone	Hydrocortisone	14	suppressed
Valsartan	Valsartan	14	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Levofloxacin	Levofloxacin	13	12
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Topiramate	Topiramate	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Megestrol Acetate	Megestrol Acetate	12	suppressed
Pregabalin	Pregabalin	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Spironolactone	Spironolactone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error